Takara Bio Inc. (JP:4974) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Takara Bio Inc. reported that despite lower-than-expected net sales for the first six months of fiscal 2024, its operating and ordinary profits significantly surpassed forecasts due to reduced SG&A expenses and lower deferred income taxes. This led to a notable increase in net income attributable to owners of the parent compared to initial projections.
For further insights into JP:4974 stock, check out TipRanks’ Stock Analysis page.